[HTML][HTML] Neuroimmune mechanisms as novel treatment targets for substance use disorders and associated comorbidities

MD Namba, JM Leyrer-Jackson, EK Nagy… - Frontiers in …, 2021 - frontiersin.org
Recent studies examining the neurobiology of substance abuse have revealed a significant
role of neuroimmune signaling as a mechanism through which drugs of abuse induce …

The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review

S Lake, MS Pierre - Clinical Psychology Review, 2020 - Elsevier
Despite high rates of cannabis use during medication-based treatment of opioid use
disorder (MOUD), uncertainty remains around how cannabis influences treatment outcomes …

[HTML][HTML] “I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion …

MC Meacham, AL Nobles, DA Tompkins, J Thrul - PloS one, 2022 - journals.plos.org
A growing body of research has reported on the potential opioid-sparing effects of cannabis
and cannabinoids, but less is known about specific mechanisms. The present research …

[HTML][HTML] The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

T Rosic, R Kapoor, B Panesar, L Naji, DB Chai… - Harm reduction …, 2021 - Springer
Background With the ongoing opioid crisis and policy changes regarding legalization of
cannabis occurring around the world, it is necessary to consider cannabis use in the context …

Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis

ME Socías, JC Choi, S Lake, E Wood… - Drug and alcohol …, 2021 - Elsevier
Background The ongoing opioid overdose crisis is driven largely by exposure to illicitly-
manufactured fentanyl. Preliminary observational and experimental research suggests that …

Cannabidiol effect on cue-induced craving for individuals with opioid use disorder treated with buprenorphine: a small proof-of-concept open-label study

J Suzuki, B Martin, S Prostko, PR Chai… - Integrative Medicine …, 2022 - liebertpub.com
Background: Opioid use disorder (OUD) remains a major public health concern. Despite the
use of medications for OUD such as buprenorphine, the current gold-standard treatment …

A cohort study examining the relationship among housing status, patient characteristics, and retention among individuals enrolled in low-barrier-to-treatment-access …

MG Gazzola, ID Carmichael, LM Madden… - Journal of substance …, 2022 - Elsevier
Background Few studies have directly compared patient characteristics and retention
among those enrolled in methadone maintenance treatment (MMT) based on housing …

[HTML][HTML] Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data

L Naji, T Rosic, N Sanger, B Dennis, A Hillmer… - Frontiers in …, 2022 - frontiersin.org
Importance It is known that only minority of patients with opioid use disorder (OUD) receive
treatment, of which only a fraction successfully complete treatment as intended. Factors …

Children and youth who use Cannabis for pain relief: benefits, risks, and perceptions

JJ Woo, EA van Reekum, T Rosic… - … Health, Medicine and …, 2020 - Taylor & Francis
We provide up-to-date perspectives on the benefits and risks of medical cannabis for pain
management in children and youth. To date, only two studies (a case report and a small …

[HTML][HTML] The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya

EW Ngarachu, SK Kiburi, FR Owiti… - … , Prevention, and Policy, 2022 - Springer
Background Cannabis use during methadone treatment may negatively impact treatment
outcomes. The aim of this study was to determine the prevalence and pattern of cannabis …